Orphan Drug - MM+M - Medical Marketing and Media

Orphan Drug

All articles by Orphan Drug

Top 25 orphan drugs, by 2015 global sales
Top 25 orphan drugs, by 2015 global sales
February 22, 2016
3:10 pm

Roche’s Rituxan generated $7.3 billion in sales in 2015, making it the top-selling orphan drug.

Orphan drug sales expected to grow 12% by 2020
Orphan drug sales expected to grow 12% by 2020
February 3, 2016
12:00 pm

Click for an infographic to learn more about orphan drugs, rare diseases and the top-selling drugs in the category.

Five things for pharma marketers to know: Wednesday, July 8
Five things for pharma marketers to know: Wednesday, July 8
John Frank
July 8, 2015
3:00 pm

CDC report finds prescription painkiller abuse contributed to an increase in heroin use; Novartis heart-failure drug gets FDA approval; Isis Pharmaceuticals obtains orphan-drug designation for volanesorsen

Five things for pharma marketers to know: Thursday, July 2
Five things for pharma marketers to know: Thursday, July 2
Jaimy Lee
July 2, 2015
3:30 pm

Biogen pursues orphan eye-disease treatments; Novo Nordisk will stop selling Tresiba in Germany over price controversy; the switch to Prevnar 13 is expected to lower costs

Everyday Health looks to compete for pharma TV budgets
Everyday Health looks to compete for pharma TV budgets
Jaimy Lee
May 12, 2015
7:00 pm

The digital health firm is expanding services to pharma customers, offering to help drugmakers maximize spending on TV and video.

Five things for pharma marketers to know: Monday, April 6
Five things for pharma marketers to know: Monday, April 6
Kevin McCaffrey
April 6, 2015
4:00 pm

Pfizer exec said biosimilar interchangeability definition not happening anytime soon; AARP launches digital health tech studies with Pfizer and UnitedHealthcare; BMS inks gene therapy collaboration deal

Horizon makes $1.1-billion rare-disease push
Horizon makes $1.1-billion rare-disease push
Deborah Weinstein
March 30, 2015
7:21 pm

Horizon Pharma’s purchase of Hyperion Therapeutics will add two rare-disease drugs to its portfolio.

Shire and Cincinnati Children’s Hospital team up in rare diseases
Shire and Cincinnati Children’s Hospital team up in rare diseases
Kevin McCaffrey
March 26, 2015
8:00 pm

The duo hope to begin testing a new treatment within three years.

Everyday Health buys rare-disease agency Cambridge BioMarketing
Everyday Health buys rare-disease agency Cambridge BioMarketing
Deborah Weinstein
March 23, 2015
8:23 pm

The $38-million deal expands the reach of rare-disease campaigns.

Five things for pharma marketers to know: Monday, March 23
Five things for pharma marketers to know: Monday, March 23
Jaimy Lee
March 23, 2015
3:15 pm

Eleven new drugs with blockbuster potential are expected to launch this year; a bill would require FDA to quickly review drugs approved in the EU; Biogen reinforces its focus on hard-to-treat diseases

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners